Increased resistance to staphylococcus aureus endophthalmitis in BALB/c mice: Fas ligand is required for resolution of inflammation but not for bacterial clearance

Infection and Immunity

Volumn 81, Issue 6, 2013, Pages 2217-2225

  Sugi, Norito ^a   Whiston, Emily A ^a   Ksander, Bruce R ^a   Gregory, Meredith S ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; MYELOPEROXIDASE;

ALLOTYPE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL LOAD; BINDING AFFINITY; CLINICAL EXAMINATION; CONTROLLED STUDY; CYTOTOXICITY; ELECTRORETINOGRAPHY; ENDOPHTHALMITIS; FEMALE; HISTOLOGY; HISTOPATHOLOGY; HOST PATHOGEN INTERACTION; IMMUNE RESPONSE; INFECTION RESISTANCE; INFLAMMATORY CELL; INNATE IMMUNITY; MALE; MOUSE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NEUTROPHIL COUNT; NONHUMAN; PRIORITY JOURNAL; RETINA INJURY; SLIT LAMP; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; STRAIN DIFFERENCE; TARGET CELL;

ANIMALS; ENDOPHTHALMITIS; FAS LIGAND PROTEIN; FEMALE; GENETIC PREDISPOSITION TO DISEASE; INFLAMMATION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PEROXIDASE; RETINA; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84877807508     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00405-12     Document Type: Article

References (48)

1. Bhagat N, Nagori S, Zarbin M. 2011. Post-traumatic infectious endophthalmitis. Surv. Ophthalmol. 56:214-251.
2. Novosad BD, Callegan MC. 2010. Severe bacterial endophthalmitis: towards improving clinical outcomes. Expert. Rev. Ophthamol. 5:689-698.
3. Taban M, Behrens A, Newcomb RL, Nobe MY, Saied G, Sweet M, McDonnell PJ. 2005. Acute endophthalmitis following cataract surgery. Arch. Ophthalmol. 123:613-620.
4. West ES, Behrens A, McDonnell PJ, Tielsch JM, Schein OD. 2005. The incidence of endophthalmitis after cataract surgery among the U.S. Medicare population increased between 1994 and 2001. Ophthalmology 112: 1388-1394.
5. Callegan MC, Gilmore MS, Gregory M, Ramadan RT, Wiskur BJ, Moyer AL, Hunt JJ, Novosad BD. 2007. Bacterial endophthalmitis: therapeutic challenges and host-pathogen interactions. Prog. Ret. Eye Res. 26:189-203.
6. Callegan MC, Engelbert M, Parke DW, Jett BD, Gilmore MS. 2002. Bacterial endophthalmitis: epidemiology, therapeutics, and bacteriumhost interactions. Clin. Microbiol. Rev. 15:111-124.
7. Gregory M, Gilmore MS, Callegan MC. 2007. Role of bacterial and host factors in infectious endophthalmitis. Chem. Immunol. Allergy 92:266-275.
8. Giese MJ, Rayner SA, Fardin B, Sumner HL, Rozengurt N, Mondino BJ, Gordon LK. 2003. Mitigation of neutrophil infiltration in a rat model of early Staphylococcus aureus endophthalmitis. Invest. Ophthalmol. Vis. Sci. 44:3077-3082.
9. Giese MJ, Sumner HL, Berliner JA, Mondino BJ. 1998. Cytokine expression in a rat model of Staphylococcus aureus endophthalmitis. Invest. Ophthalmol. Vis. Sci. 39:2785-2790.
10. Engelbert M, Gilmore MS. 2005. Fas ligand but not complement is critical for control of experimental Staphylococcus aureus endophthalmitis. Invest. Ophthalmol. Vis. Sci. 46:2479-2486.
11. Otoonello L, Tortolina G, Amelotti M, Dallegri F. 1999. Soluble Fas ligand is chemotactic for human neutrophilic polymorphonuclear leukocytes. J. Immunol. 162:3601-3606.
12. Seino K, Iwabuchi K, Kayagaki N, Miyata R, Nagaoka I, Matsuzawa A, Fukao Y, Yagita H, Okumura K. 1998. Chemotactic activity of soluble Fas ligand against phagocytes. J. Immunol. 161:4484-4488.
13. Griffith T, Brunner T, Fletcher SM, Green DR, Ferguson TA. 1995. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270:1189.
14. Hohlbaum AM, Moe S, Marshak-Rothstein A. 2000. Opposing effects of transmembrane and soluble Fas ligand expression on inflammation and tumor cell survival. J. Exp. Med. 191:1209.
15. Gregory M, Saff RR, Marshak-Rothstein A, Ksander BR. 2007. Control of ocular tumor growth and metastatic spread by soluble and membrane Fas ligand. Cancer Res. 67:11951-11958.
16. Gregory MS, Repp AC, Hohlbaum AM, Saff RR, Marshak-Rothstein A, Ksander BR. 2002. Membrane Fas ligand activates innate immunity and terminates ocular immune privilege. J. Immunol. 169:2727-2735.
17. Kayagaki N, Yamaguchi N, Nagao F, Matsuo S, Maeda H, Okumura K, Yagita H. 1994. Polymorphism of murine Fas ligand that affects the biological activity. Proc. Natl. Acad. Sci. U. S. A. 94:3914-3919.
18. Cao Y, Miao X, Huang M, Deng L, Lin D, Zeng Y, Shao J. 2010. Polymorphisms of death pathway genes Fas and FasL and risk of nasopharyngeal carcinoma. Mol. Carcinog. 49:944-950.
19. Sun T, Miao X, Zhang X, Tan W, Xiong P, Lin D. 2004. Polymorphisms of death pathway genes FAS and FasL in esophageal squamous-cell carcinoma. J. Nat. Can. Inst. 96:1030-1036.
20. Wang W, Zheng Z, Yu W, Lin H, Cui B, Cao F. 2012. Polymorphisms of the Fas and FasL genes and risk of breast cancer. Oncol. Let. 3:625-628.
21. Whiston E, Sugi N, Kamradt MC, Sack C, Heimer S, Engelbert M, Gilmore MS, Ksander BR, Gregory M. 2008. αB-crystallin protects retinal tissue during S. aureus-induced endophthalmitis. Infect. Immun. 76:1781-1790.
22. Chen J, Nathans J. 2007. Genetic ablation of cone photoreceptors eliminates retinal folds in the retinal degeneration 7 (rd7) mouse. Invest. Ophthalmol. Vis. Sci. 48:2799-2805.
23. Iribarne M, Ogawa L, Torbidoni V, Dodds CM, Dodds RA, Suburo AM. 2008. Blockade of endothelinergic receptors prevents development of proliferative vitreoretinopathy in mice. Am. J. Pathol. 172:1030-1042.
24. Giese MJ, Berliner JA, Reisner A, Wagar EA, Mondino BJ. 1999. A comparison of the early inflammatory effects of an agr-/sar- versus a wild type strain of Staphylococcus aureus in a rat model of endophthalmitis. Curr. Eye Res. 18:177-185.
25. Ferguson TA, Griffith TS. 2006. A vision of cell death: Fas ligand and immune privilege 10 years later. Immunol. Rev. 213:228-238.
26. Hohlbaum AM, Gregory MS, Ju S-T, Marshak-Rothstein A. 2001. Fas-ligand engagement of resident peritoneal macrophages in vivo induces apoptosis and the production of neutrophil chemotactic factors. J. Immunol. 167:6217-6224.
27. Ju S-T, Panka DJ, Cui H, Ettinger R, El-Khatib M, Sherr DH, Stanger BZ, Marshak-Rohstein A. 1995. Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373:444-448.
28. Kagi D, Vignaux F, Ledemann B, Burki K, Depraetere V, Nagata S, Hengartner H, Golstein P. 1994. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265:528-530.
29. Lee HO, Ferguson TA. 2003. Biology of FasL. Cytokine Growth Factor Rev. 14:325-335.
30. Park S-M, Schickel R, Peter ME. 2005. Nonapoptotic functions of FADD-binding death receptors and their signaling molecules. Curr. Opin. Cell Biol. 17:610-616.
31. Rescigno M, Piguet V, Valzasina B, Lens S, Zubler R, French L, Kindlr V, Tschopp J, Ricciardi-Castagnoli P. 2000. Fas engagement induces the maturation of dendritic cells (DCs), the release of interleukin (IL)-1beta, and the production of gamma interferon in the absence of IL-12 during DC-T cell cognate interaction: a new role for Fas ligand in inflammatory responses. J. Exp. Med. 192:1661-1668.
32. Gao Y, Herndon JM, Zhang H, Griffith S, Ferguson TA. 1998. Antiinflammatory effects of CD95 ligand (FasL)-induced apoptosis. J. Exp. Med. 188:887-896.
33. Gorham JD, Guler ML, Steen RG, Mackey AJ, Daly MJ, Frederick K, Dietrich WF, Murphy KM. 1996. Genetic mapping of a murine locus controlling development of T helper 1/ T helper 2 type responses. Proc. Natl. Acad. Sci. U. S. A. 93:12467-12472.
34. Hazlett LD, McClellan S, Kwon B, Barrett R. 2000. Increased severity of Pseudomonas aeruginosa corneal infection in strains of mice designated Th1 versus Th2 responsive. Invest. Ophthalmol. Vis. Sci. 41:805-810.
35. Hume EB, Cole N, Khan S, Garthwaite LL, Aliwarga Y, Schubert TL, Willcox MDP. 2005. A Staphylococcus aureus mouse keratits topical infection model: cytokine balance in different strains of mice. Immunol. Cell Biol. 83:294-300.
36. Britbach K, Wongprompitak P, Steinmetz I. 2011. Distinct role for nitric oxide in resistant C57BL/6 and susceptible BALB/c mice to control Burkholderia pseudomallei infection. BMC Immunol. 12:20.
37. Kockritz-Blickwede M, Rohde M, Oehmcke S, Miller LS, Cheung AL, Herwald H, Foster S, Mdina E. 2008. Immunological mechanisms underlying the genetic predisposition to severe Staphylococcus aureus infection in the mouse model. Am. J. Pathol. 173:1657-1668.
38. Packiam M, Veit SJ, Andeson DJ, Ingalls RR, Jerse AE. 2010. Mouse strain-dependent differences in susceptibility to Neisseria gonorrhoeae infection and induction of innate immune responses. Infect. Immunity 78: 433-440.
39. Hazlett LD. 2002. Pathogenic mechanisms of P. aeruginosa keratitis: a review of the role of T cells, Langerhans cells, PMN, and cytokines. DNA Cell Biol. 21:383-390.
40. Beyer TL, Vogler G, Sharma D, O'Donnell FE, Jr. 1984. Protective barrier effect of the posterior lens capsule in exogenous bacterial endophthalmitis: an experimental primate study. Invest. Ophthalmol. Vis. Sci. 25:108-112.
41. Maylath FR, Leopold JH. 1955. Study of experimental ocular infection. Am. J. Ophthalmol. 40:86-101.
42. Keshari RS, Jyoti A, Dubey M, Kothari N, Kohli M, Bogra J, Barthwal MK, Dikshit M. 2012. Cytokines induced neutrophil extracellular traps formation: implication for the inflammatory disease condition. PLoS One 7(10):e48111. doi:10.1371/journal.pone.0048111.
43. Tsuda Y, Takahashi H, Kobayashi M, Hanafusa T, Herndon DN, Suzuki F. 2004. Three different neutrophil subsets exhibited in mice with different susceptibilities to infection by methicillin-resistant Staphylococcus aureus. Immunity 21:215-226.
44. Nippe N, Varga G, Holzinger D, Loffler B, Medina E, Becker K, Roth J, Ehrchen JM, Sunderkotter C. 2011. Subcutaneous infection with S. aureus in mice reveals association of resistance with influx of neutrophils and Th2 response. J. Investig. Dermatol. 131:125-132.
45. Gregory MS, Hackett CG, Abernathy EF, Lee KS, Saff RR, Hohlbaum AM, Moody KS, Hobson MW, Jones A, Kolovou P, Karray S, Giani A, John SW, Chen DF, Marshak-Rothstein A, Ksander BR. 2011. The form of Fas ligand determines retinal ganglion cell survival during glaucoma. PLoS One 6(3):e17659. doi:10.1371/journal.pone.0017659.
46. Ju KR, Kim HS, Kim JH, Lee NY, Park CK. 2006. Retinal glial cell responses and Fas/FasL activation in rats in chronic ocular hypertension. Brain Res. 1122:209-221.
47. Kaplan HJ, Leibole MA, Tezel T, Ferguson TA. 1999. Fas ligand (CD95 ligand) controls angiogenesis beneath the retina. Nat. Med. 5:292-297.
48. Zhou Z, Wu M, Barrett RP, McClellan SA, Zhang Y, Hazlett LD. 2010. Role of the Fas pathway in Pseudomonas aeruginosa keratitis. Invest. Ophthalmol. Vis. Sci. 51:2537-2547.